Music Therapy to Address Patients' Journeys With Chronic Illness, Outcomes, and Readmission
Conduct a pilot study (n = 20) to explore the feasibility and acceptability of the MAJOR CHORD music therapy (MT) intervention (i.e., two in-person MT sessions prior to discharge and two virtual MT sessions post-discharge) and collection of patient-reported outcomes through 30 days after hospital discharge. The investigators will uncover any potential modifications that need to be made to the intervention and data collection process prior to initiating the randomized trial.
Conditions:
🦠 Heart Failure 🦠 Chronic Obstructive Pulmonary Disease
🗓️ Study Start (Actual) 15 January 2024
🗓️ Primary Completion (Estimated) 30 June 2024
✅ Study Completion (Estimated) 30 June 2024
👥 Enrollment (Estimated) 20
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Cleveland, Ohio, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Age range: ≥40 to ≤89 years
    • * Hospitalized at UH Cleveland Medical Center (UHCMC) with anticipated length of stay following recruitment ≥ 2 days as documented in electronic health record (EHR)
    • * Diagnosed (i.e., ICD-10 code within the EHR) with either COPD (J44) or HF (I50) with confirmed ICD-10 code in EHR
    • * Able to read and understand English
    • * Screening positive for depression and/or anxiety as evidenced by: GAD-7 anxiety score ≥ 10 and PHQ-9 depression score ≥ 10
    • * Access to WiFi, active email address \& laptop, tablet, and/or PC with videoconferencing capabilities
    • * Has reliable support person who can be available to respond in case of a medical emergency at any time
    • * Has reliable access to a mobile device with active data plan

    Exclusion Criteria:

    • * Significant hearing and/or visual impairment as documented in EHR
    • * Unable to independently provide consent (i.e., no proxy consent)
    • * Active suicidal ideation documented in inpatient psychiatry note during current hospital admission or expressed at any point verbally or in writing to study staff
    • * Severe psychological comorbidity (e.g., psychosis, schizophrenia) that would prevent patient from engaging fully in intervention as documented in EHR
    • * Currently admitted to intensive care unit
    • * Receiving active cancer treatment (e.g., chemotherapy, radiation, immunotherapy) as documented in EHR
    • * Diagnosed with medical condition likely to be terminal within 24 weeks as documented in EHR
    • * On wait list for heart transplantation or ventricular assist device (VAD) as documented in EHR
    • * NYHA Stage IV HF or end-stage COPD as documented in EHR
    • * Receiving hospice care as documented in EHR
    • * Active substance abuse as documented in EHR
Ages Eligible for Study: 40 Years to 89 Years (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 9 January 2024
  • First Submitted that Met QC Criteria 9 January 2024
  • First Posted 19 January 2024

Study Record Updates

  • Last Update Submitted that Met QC Criteria 26 January 2024
  • Last Update Posted 30 January 2024
  • Last Verified January 2024